As AML is the second most common childhood leukemia, we utilized the TARGET pediatric study to analyze ETFA and ETFB expression and again found down-regulation or no significant change of ETFA and ETFB in most subtypes of AML (Supplementary Fig. 2A) [4]. The gene discussed is ETFB; the disease is leukemia.